{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:57:10Z","timestamp":1791946630399,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cmi.2019.03.028","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T10:38:40Z","timestamp":1554547120000},"page":"792-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":655,"title":["Resistance of Candida to azoles and echinocandins worldwide"],"prefix":"10.1016","volume":"25","author":[{"given":"K.E.","family":"Pristov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Ghannoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.03.028_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","article-title":"Fungal vaccines, mechanism of actions and immunology: a comprehensive review","volume":"109","author":"Nami","year":"2018","journal-title":"Biomed Pharm"},{"key":"10.1016\/j.cmi.2019.03.028_bib2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1590\/0074-02760150335","article-title":"New insight on the development on fungal vaccines: from immunity to recent challenges","volume":"110","author":"Medici","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cmi.2019.03.028_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jiac.2018.10.007","article-title":"Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital","volume":"25","author":"Sakagami","year":"2019","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.cmi.2019.03.028_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7495218","article-title":"Antifungal susceptibility and biofilm production of Candida spp. isolated from clinical samples","author":"Marak","year":"2018","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib5","doi-asserted-by":"crossref","first-page":"204237","DOI":"10.1155\/2013\/204237","article-title":"Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents","volume":"2013","author":"Spampinato","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.cmi.2019.03.028_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-5-22","article-title":"Risk factors for fatal candidemia caused by Candida albicans and non-Candida species","volume":"5","author":"Cheng","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1473-3099(17)30442-5","article-title":"Immunotherapeutic approaches to treatment of fungal diseases","volume":"17","author":"Armstrong-James","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0255-0857.124300","article-title":"Species distribution and drug susceptibility of Candida in clinical isolates from a tertiary care center at Indore","volume":"32","author":"Nirkhiwale","year":"2014","journal-title":"Ind J Med Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib10","first-page":"3635","article-title":"Candida albicans forms biofilms on the vaginal mucosa","volume":"156","author":"Harriott","year":"2010","journal-title":"Microbiologia"},{"key":"10.1016\/j.cmi.2019.03.028_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib12","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1038\/s41467-018-06944-1","article-title":"Candida albicans gains azole resistance by altering sphingolipid composition","volume":"9","author":"Gao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2019.03.028_bib13","article-title":"Transcriptomic and genomic approaches for unravelling the Candida albicans biofilm formation and drug resistance\u2014an update","volume":"11","author":"Chong","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.cmi.2019.03.028_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tcsw.2018.09.001","article-title":"Yeast species-specific, differential inhibition of \u03b2-1,3-d-glucan synthesis by poacic acid and caspofungin","volume":"3","author":"Lee","year":"2018","journal-title":"Cell Surf"},{"key":"10.1016\/j.cmi.2019.03.028_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","article-title":"A\u00a0Candida auris outbreak and its control in an intensive care setting","volume":"379","author":"Eyre","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.03.028_bib16","article-title":"Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata","volume":"63","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.03.028_bib17","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"26","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00294-013-0400-3","article-title":"Recent insights into Candida albicans biofilm resistance mechanisms","volume":"59","author":"Mathe","year":"2013","journal-title":"Curr Genet"},{"key":"10.1016\/j.cmi.2019.03.028_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"2","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.03.028_bib21","first-page":"120","article-title":"Resistance to antifungal agents: mechanisms and clinical impacts","volume":"46","author":"Kanafani","year":"2008","journal-title":"Antimicrobiol Resist"},{"key":"10.1016\/j.cmi.2019.03.028_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/EC.00060-10","article-title":"Genomic plasticity of the human fungal pathogen Candida albicans","volume":"9","author":"Selmecki","year":"2010","journal-title":"Euk Cell"},{"key":"10.1016\/j.cmi.2019.03.028_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/0037-8682-0461-2016","article-title":"Antifungal activity of synthetic antiseptics and natural compounds against Candida dubliniensis before and after in\u00a0vitro fluconazole exposure","volume":"50","author":"Reginato","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.cmi.2019.03.028_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1567-1356(03)00240-X","article-title":"Comparison of epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans","volume":"4","author":"Sullivan","year":"2004","journal-title":"FEMS Yeast Rev"},{"key":"10.1016\/j.cmi.2019.03.028_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01555-18","article-title":"Monitoring of fluconazole and caspofungin activity against in\u00a0vivo Candida glabrata biofilms by bioluminescence imaging","volume":"63","author":"Persyn","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.03.028_bib26","first-page":"11","article-title":"Candida glabrata biofilms: how far have we come?","volume":"3","author":"Rodrigues","year":"2017","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.cmi.2019.03.028_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis, and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.03.028_bib28","article-title":"Biofilm formations in Candida glabrata: what have we learnt from functional genomics approaches?","volume":"16","author":"d\u2019Enfert","year":"2016","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.cmi.2019.03.028_bib29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"4","author":"Pfaller","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fgb.2009.09.003","article-title":"Fungal echinocandin resistance","volume":"2","author":"Walker","year":"2010","journal-title":"Fungal Gene Biol"},{"key":"10.1016\/j.cmi.2019.03.028_bib31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in C.\u00a0glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QCO.0000000000000215","article-title":"Clinical perspectives on echinocandin resistance among Candida species","volume":"28","author":"Shields","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib33","first-page":"119","article-title":"Adhesins of yeasts: protein structure and interactions","volume":"4","author":"Willaert","year":"2018","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.cmi.2019.03.028_bib34","article-title":"Echinocandin-induced microevolution of Candida parapsilosis influences virulence and abiotic stress tolerance","volume":"3","author":"Papp","year":"2018","journal-title":"Am Soc Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib35","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3389\/fmicb.2018.02997","article-title":"An azole-resistant Candida parapsilosis outbreak: clonal persistence in the intensive care unit of a Brazilian teaching hospital","volume":"9","author":"Thomaz","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00651-17","article-title":"Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis","volume":"61","author":"Rybak","year":"2017","journal-title":"Antimicrobiol Agents Chemother"},{"key":"10.1016\/j.cmi.2019.03.028_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12929-017-0376-2","article-title":"Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens","volume":"24","author":"Neji","year":"2017","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.cmi.2019.03.028_bib38","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib39","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fmicb.2017.01927","article-title":"An update on Candida tropicalis based on basic and clinical approaches","volume":"8","author":"Zuza-Alves","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib40","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"5","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2019.03.028_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/myc.12439","article-title":"Molecular mechanisms associated with fluconazole resistance in clinical Candida albicans isolates from India","volume":"59","author":"Mane","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.03.028_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris","volume":"6","author":"Cortegiani","year":"2018","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.cmi.2019.03.028_bib44","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.03.028_bib45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multi-drug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.03.028_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First hospital outbreak of globally emerging Candida auris in a European hospital","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.03.028_bib47","series-title":"Posting date. Recommendations for treatment of Candida auris infections","author":"Center for Disease Control and Prevention 21 December","year":"2018"},{"key":"10.1016\/j.cmi.2019.03.028_bib48","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2019.03.028_bib49","series-title":"Posting date. General Information about Candida auris","year":"2017"},{"key":"10.1016\/j.cmi.2019.03.028_bib50","series-title":"Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris","year":"2017"},{"key":"10.1016\/j.cmi.2019.03.028_bib51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhin.2017.09.009","article-title":"Controlling a possible outbreak of Candida auris infections: lessons learnt from multiple interventions","volume":"97","author":"Biswal","year":"2017","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.03.028_bib52","article-title":"Antifungal resistance: specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus","volume":"4","author":"Arikan-Akdagli","year":"2018","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.cmi.2019.03.028_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1017\/ice.2017.127","article-title":"Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species","volume":"9","author":"Piedrahita","year":"2017","journal-title":"Inf Con Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib54","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1017\/ice.2017.162","article-title":"Effectiveness of disinfectants against Candida auris and other Candida species","volume":"38","author":"Cadnum","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.03.028_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhin.2017.08.019","article-title":"Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris","volume":"97","author":"Moore","year":"2017","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.03.028_bib56","series-title":", posting date. Candida auris colonization","year":"2018"},{"key":"10.1016\/j.cmi.2019.03.028_bib57","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/jac\/dkr114","article-title":"Squalamine ointment for Staphylococcus aureus skin decolonization in a mouse model","volume":"66","author":"Djouhri-Bouktab","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19301491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19301491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:22:37Z","timestamp":1761117757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19301491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1198743X19301491"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance of Candida to azoles and echinocandins worldwide","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}